![Alise Reicin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 15 M $ in data 30/06/2026
Alise S.
Reicin currently works at Tectonic Therapeutic, Inc., as President, Chief Executive Officer & Director from 2020, Tectonic Operating Co., Inc., as President, Chief Executive Officer & Director from 2020, Sharsheret, Inc., as Director, Sana Biotechnology, Inc., as Independent Director from 2020, Immatics NV, as Non-Executive Director from 2024, and Israel Biotech Fund, as Venture Advisor.
Dr. Reicin also formerly worked at AVROBIO, Inc., as Chief Executive Officer & Director, Homology Medicines, Inc., as Independent Director, Celgene Corp., as President-Global Clinical Development from 2018 to 2019, Merck & Co., Inc., as VP-Oncology Program & Pipeline Leadership, and EMD Serono, Inc., as SVP & Head-Global Clinical Development from 2015 to 2018.
Dr. Reicin received her undergraduate degree in 1982 from Barnard College and doctorate degree in 1987 from Harvard Medical School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
2,32% | 20/06/2026 | 437.653 ( 2,32% ) | 15 M $ | 30/06/2026 |
IMMATICS N.V. -.--% | 16/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| 04/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Direttore/Membro del Consiglio | 01/12/2020 |
| IMMATICS N.V. | Direttore/Membro del Consiglio | 29/07/2024 |
Tectonic Therapeutic, Inc.
 Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies | Amministratore Delegato | 01/08/2020 |
Sharsheret, Inc.
 Sharsheret, Inc. Miscellaneous Commercial ServicesCommercial Services Non-Profit Organization | Direttore/Membro del Consiglio | - |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consulente / Consigliere | - |
| Società | Posizione | Fine |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/12/2019 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Direttore Tecnico/Scientifico/R&S | 01/10/2018 |
| TECTONIC THERAPEUTIC, INC. | Amministratore Delegato | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| ░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Barnard College
 Barnard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sharsheret, Inc.
Sharsheret, Inc. Miscellaneous Commercial ServicesCommercial Services Non-Profit Organization | Commercial Services |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
